
- Volume 0 0
Promising News on Stem Cells
In the future, type 1 diabetes patients may be able to avoid the need for daily insulin shots through transplants of insulin-producing stem cells. ?We have done 38 islet cell transplant procedures since 1999,? said Dr. Jonathan Lakey of the University of Alberta in Edmonton. ?And 87% of those patients are free of insulin therapy a year after transplantation.? (The islets of Langerhans are the insulin-making parts of the pancreas.)
The news is especially exciting because there is an acute shortage of transplantable pancreases worldwide. Stem cell therapy also reduces or eliminates transplant rejections. More work is necessary, however, including satisfying the concerns of those who object to using stem cells on ethical grounds.
Articles in this issue
over 23 years ago
Genetic Differences and Medicinesover 23 years ago
A Hidden Clotting Problem?over 23 years ago
Aspirin Delays Premature Laborover 23 years ago
Hypertension and Dementiaover 23 years ago
Educating High-Risk Groups About Diabetesover 23 years ago
Interactive Web Site Promotes Diabetes Controlover 23 years ago
Sometimes You Feel Like a Nutover 23 years ago
Low Birth Weight Associated with Risk for Diabetesover 23 years ago
Pumping Iron and Beating Diabetesover 23 years ago
Regular Use of Inhalers Reduces Hospital AdmissionNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























